Skip to content

The Safety and Efficacy of Esophageal Thin Metallic Stent for Stricture after Radiotherapy

The Safety and Efficacy of Esophageal Thin Metallic Stent for Stricture after Radiotherapy - Ethics trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029869
Enrollment
20
Registered
2017-11-09
Start date
2017-11-13
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

Shizuoka Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Cases of esophageal thin metallic stent placement for stricture after radiotherapy 2) Patients with informed consent

Exclusion criteria

Exclusion criteria: 1) Patient is judged to be inappropriate for enrollment of the study for any reason by the investigator

Design outcomes

Primary

MeasureTime frame
Occurrence rate of esophageal hemorrhage, esophageal perforation, and mediastinal infection which CTCAE grade is not less than 3

Secondary

MeasureTime frame
Occurrence rate and the types of adverse events Patient-reported best dysphagia score after stent placement Time periods while patient-reported dysphagia score is no more than 2 Survival time after stent placement

Countries

Japan

Contacts

Public ContactKatsuyuki Murai

Shizuoka Cancer Center Division of Endoscopy

k.murai@scchr.jp055-989-5222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026